Targeted Biopsies Identify Larger Proportions of Patients With Colonic Neoplasia Undergoing High-Definition Colonoscopy, Dye Chromoendoscopy, or Electronic Virtual Chromoendoscopy

Clinical Gastroenterology and Hepatology

Volumn 14, Issue 5, 2016, Pages 704-712.e4

  Gasia, Miriam F ^a   Ghosh, Subrata ^a   Panaccione, Remo ^a   Ferraz, Jose G ^a   Kaplan, Gilaad G ^a   Leung, Yvette ^a   Novak, Kerri L ^a   Seow, Cynthia H ^a   Iacucci, Marietta ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Colon Cancer Screening; Colorectal Tumor; Detection; Endoscopic Imaging

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOENDOSCOPY; COLON BIOPSY; COLON TUMOR; COLONOSCOPY; CROHN DISEASE; DEMOGRAPHY; DISEASE DURATION; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; SEX RATIO; ULCERATIVE COLITIS; BIOPSY; CANADA; COLONIC NEOPLASMS; COMPARATIVE STUDY; COMPLICATION; CYTOCHEMISTRY; ENDOSCOPY; EVALUATION STUDY; INFLAMMATORY BOWEL DISEASE; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TERTIARY CARE CENTER; YOUNG ADULT;

ADULT; AGED; BIOPSY; CANADA; COLONIC NEOPLASMS; ENDOSCOPY; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TERTIARY CARE CENTERS; YOUNG ADULT;

EID: 84961168058     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2015.12.047     Document Type: Article

References (40)

1. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
2. Ekbom A., Helmick C., Zack M., et al. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990, 336:357-359.
3. Eaden J.A., Mayberry J.F. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002, 51(Suppl 5):V10-V12.
4. Winawer S., Fletcher R., Rex D., et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003, 124:544-560.
5. The role of colonoscopy in the management of patients with inflammatory bowel disease. Gastrointest Endosc 1998, 48:689-690. American Society for Gastrointestinal Endoscopy.
6. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124:880-888.
7. Matsumoto T., Nakamura S., Jo Y., et al. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol 2003, 98:1827-1833.
8. Rutter M.D., Saunders B.P., Schofield G., et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004, 53:256-260.
9. Marion J.F., Waye J.D., Present D.H., et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol 2008, 103:2342-2349.
10. Gunther U., Kusch D., Heller F., et al. Surveillance colonoscopy in patients with inflammatory bowel disease: comparison of random biopsy vs. targeted biopsy protocols. Int J Colorectal Dis 2011, 26:667-672.
11. Picco M.F., Pasha S., Leighton J.A., et al. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis. Inflamm Bowel Dis 2013, 19:1913-1920.
12. Subramanian V., Mannath J., Ragunath K., et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33:304-312.
13. Soetikno R., Subramanian V., Kaltenbach T., et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 2013, 144:1349-1352. 52 e1-6.
14. Laine L., Kaltenbach T., Barkun A., et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 2015, 148:639-651.
15. Mooiweer E., van der Meulen-de Jong A.E., Ponsioen C.Y., et al. Chromoendoscopy for surveillance in inflammatory bowel disease does not increase neoplasia detection compared with conventional colonoscopy with random biopsies: results from a large retrospective study. Am J Gastroenterol 2015, 110:1014-1021.
16. Iacucci M., Gasia M.F., Urbanski S.J., et al. A randomized comparison of high definition colonoscopy alone with high definition dye spraying and electronic virtual chromoendoscopy using iSCAN for detection of colonic dysplastic lesions during IBD surveillance colonoscopy. Gastroenterology 2015, 148. S-74.
17. Noor Mohammed, Prashant Kant, Faisal Abid, et al. High definition white light endoscopy (Hdwle) versus high definition with chromoendoscopy (Hdce) in the detection of dysplasia in long standing ulcerative colitis: a randomized controlled trial. Gastrointest Endosc 2015, 81. AB148.
18. Eaden J., Abrams K., Ekbom A., et al. Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 2000, 14:145-153.
19. Eaden J.A., Ward B.A., Mayberry J.F. How gastroenterologists screen for colonic cancer in ulcerative colitis: an analysis of performance. Gastrointest Endosc 2000, 51:123-128.
20. Obrador A., Ginard D., Barranco L. Review article: colorectal cancer surveillance in ulcerative colitis - what should we be doing?. Aliment Pharmacol Ther 2006, 24(Suppl 3):56-63.
21. Iacucci M., Uraoka T., Fort Gasia M., et al. Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease. Can J Gastroenterol Hepatol 2014, 28:361-370.
22. Jess T., Simonsen J., Jorgensen K.T., et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012, 143:375-381 e1. quiz e13-e14.
23. Claessen M.M., Vleggaar F.P., Tytgat K.M., et al. High lifetime risk of cancer in primary sclerosing cholangitis. J Hepatol 2009, 50:158-164.
24. Jayaram H., Satsangi J., Chapman R.W. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction?. Gut 2001, 48:430-434.
25. Iacucci M., Hassan C., Fort Gasia M., et al. Serrated adenoma prevalence in inflammatory bowel disease surveillance colonoscopy, and characteristics revealed by chromoendoscopy and virtual chromoendoscopy. Can J Gastroenterol Hepatol 2014, 28:589-594.
26. Hoffman A., Kagel C., Goetz M., et al. Recognition and characterization of small colonic neoplasia with high-definition colonoscopy using i-Scan is as precise as chromoendoscopy. Dig Liver Dis 2010, 42:45-50.
27. D'Haens G., Sandborn W.J., Feagan B.G., et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007, 132:763-786.
28. The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003, 58:S3-S43.
29. Schlemper R.J., Riddell R.H., Kato Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47:251-255.
30. Itzkowitz S.H., Harpaz N. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 2004, 126:1634-1648.
31. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004, 60:334-339.
32. Bernstein C.N., Shanahan F., Weinstein W.M. Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis?. Lancet 1994, 343:71-74.
33. Van Assche G., Dignass A., Bokemeyer B., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013, 7:1-33.
34. Marion JF. Chromoendoscopy: this is what progress looks like. AGA Perspect 2015;June/July.
35. Ullman TA. Chromoendoscopy: still not ready for prime time. AGA Perspect 2015;June/July.
36. Higgins P.D. Editorial: miles to go on the SCENIC route: should chromoendoscopy become the standard of care in IBD surveillance?. Am J Gastroenterol 2015, 110:1035-1037.
37. Hurlstone D.P., Sanders D.S., Lobo A.J., et al. Indigo carmine-assisted high-magnification chromoscopic colonoscopy for the detection and characterisation of intraepithelial neoplasia in ulcerative colitis: a prospective evaluation. Endoscopy 2005, 37:1186-1192.
38. Dekker E., van den Broek F.J., Reitsma J.B., et al. Narrow-band imaging compared with conventional colonoscopy for the detection of dysplasia in patients with longstanding ulcerative colitis. Endoscopy 2007, 39:216-221.
39. van den Broek F.J., Fockens P., van Eeden S., et al. Narrow-band imaging versus high-definition endoscopy or the diagnosis of neoplasia in ulcerative colitis. Endoscopy 2011, 43:108-115.
40. Leifeld L., Rogler G., Stallmach A., et al. White-light or narrow-band imaging colonoscopy in surveillance of ulcerative colitis: a prospective multicenter study. Clin Gastroenterol Hepatol 2015, 13:1776-1781.